Telomeres Might Predict Lung Cancer Recurrence
Telomeres are sections of DNA that tell an interesting story about lifespan. Shorter telomeres usually suggest a shorter life -- but new research by a Wilmot lung cancer expert shows that longer telomeres might be a promising biomarker for a recurrence of early stage lung cancer.
URMC scientists are honoring decades of investigating the impact of environmental exposures on health— dating back to the 1940s when they first looked into the toxicants used in the atomic bomb, to more modern concerns like lead, mercury, air pollution, pesticides, nanomaterials, and epigenetics.
9/17/2015 | 0 comments
Researchers at the University of Rochester School of Medicine and Dentistry have uncovered how a new class of antibiotics works. Their findings may lead to development of drugs that could someday be a key weapon in the fight against deadly antibiotic-resistant superbugs.
9/8/2015 | 0 comments
Despite guidelines to restrict blood transfusions, a wide variation in practice persists across New York State, resulting in complications such as infections and pneumonia, a URMC study concluded.
8/19/2015 | 0 comments
The discovery of a new way that platelets get switched on after a heart attack or stroke may help inform the development of drugs that prevent dangerous clots in patients.
8/18/2015 | 0 comments
A small number of testicular cancer patients—about 11 in 6,909—died of cardiovascular disease in their first year after diagnosis and treatment with chemotherapy, a statistic that’s noteworthy because the cancer itself is usually curable and tends to afflict young men, according to a Wilmot Cancer Institute study.
8/4/2015 | 0 comments